ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Ab Science

Ab Science (AB)

1.80
-0.016
( -0.88% )
Actualizado: 08:33:34

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
1.80
Postura de Compra
1.784
Postura de Venta
1.81
Volume Operado de la Acción
53,436
1.77 Rango del Día 1.82
0.77 Rango de 52 semanas 4.465
Capitalización de Mercado [m]
Precio Anterior
1.816
Precio de Apertura
1.796
Última hora de negociación
08:33:34
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
162,636
Acciones en circulación
52,071,069
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-7.73
Beneficio por acción (BPA)
-0.23
turnover
970k
Beneficio neto
-11.99M

Acerca de Ab Science

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Paris, Paris, Fra
Fundado
-
Ab Science is listed in the Pharmaceutical Preparations sector of the Euronext with ticker AB. The last closing price for Ab Science was 1.82 €. Over the last year, Ab Science shares have traded in a share price range of 0.77 € to 4.465 €.

Ab Science currently has 52,071,069 shares in issue. The market capitalisation of Ab Science is 94.56 € million. Ab Science has a price to earnings ratio (PE ratio) of -7.73.

AB Últimas noticias

AB Science fournit un résumé de la conférence virtuelle qui s’est tenue le 16 décembre 2024

AB Science fournit un résumé de la conférence virtuelle qui s’est tenue le 16 décembre 2024 COMMUNIQUÉ DE PRESSE AB SCIENCE FAIT LE POINT SUR LA MOLECULE AB8939, UN NOUVEAU DÉSTABILISATEUR DE...

AB Science provides a summary of the webcast held on December 16, 2024

AB Science provides a summary of the webcast held on December 16, 2024 PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON AB8939, A NOVEL MICROTUBULE DESTABILIZER ESCAPING MULTIDRUG RESISTANCE AND...

AB Science provides a summary of the webcast held on December 16, 2024

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON AB8939, A NOVEL MICROTUBULE DESTABILIZER ESCAPING MULTIDRUG RESISTANCE AND STEM CELL TARGETED ALDH INHIBITOR, CURRENTLY IN PHASE 1 Paris, 17 December...

AB Science tiendra une conférence virtuelle le lundi 16 décembre 2024, de 17h30 à 18h30

AB Science tiendra une conférence virtuelle le lundi 16 décembre 2024, de 17h30 à 18h30 COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 16 DECEMBRE 2024, DE 17H30 A 18H30...

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET

PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CET Paris, 11 December, 2024, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) will host...

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CET...

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE THIS DECISION FURTHER STRENGTHENS MASITINIB’S...

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 17 October, 2024...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.1327.913669064751.6681.9481.4621877321.73648295DE
40.924105.4794520550.8762.340.8754358591.76695952DE
120.85490.27484143760.9462.340.771626361.59058811DE
260.7571.42857142861.052.340.77899291.47894348DE
52-1.38-43.39622641513.184.4650.771163971.89827207DE
156-8.85-83.098591549310.6511.190.771040394.16532084DE
260-5.4-757.221.750.771479078.32155089DE

AB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Ab Science?
El precio actual de las acciones de Ab Science es 1.80 €
¿Cuántas acciones de Ab Science están en circulación?
Ab Science tiene 52,071,069 acciones en circulación
¿Cuál es la capitalización de mercado de Ab Science?
La capitalización de mercado de Ab Science es EUR 94.56M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Ab Science?
Ab Science ha negociado en un rango de 0.77 € a 4.465 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Ab Science?
El ratio precio/beneficio de Ab Science es -7.73
¿Cuál es el ratio de efectivo a ventas de Ab Science?
El ratio de efectivo a ventas de Ab Science es 95.7
¿Cuál es la moneda de reporte de Ab Science?
Ab Science presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Ab Science?
El último ingresos anual de Ab Science es EUR 970k
¿Cuál es el último beneficio anual de Ab Science?
El último beneficio anual de Ab Science es EUR -11.99M
¿Cuál es la dirección registrada de Ab Science?
La dirección registrada de Ab Science es 3 AVENUE GEORGE V, PARIS, PARIS, 75008
¿Cuál es la dirección del sitio web de Ab Science?
La dirección del sitio web de Ab Science es www.ab-science.com
¿En qué sector industrial opera Ab Science?
Ab Science opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
DMSBSDiagnostic Medical Systems
0.007 €
(75.00%)
36.27k
GTRDSGroupe Tera DS
0.124 €
(48.50%)
32.35k
POXELPoxel
0.337 €
(38.11%)
4.65M
ALDOLDolfines
4.015 €
(17.91%)
71.64k
EEMElectricite et Eaux de Madagascar
4.30 €
(16.22%)
50
DRVDSDrone Volt DS
0.001 €
(-44.44%)
615.06k
HYPDSHipay Group DS
0.014 €
(-30.00%)
27.45k
NICBSNicox SA
0.0178 €
(-22.61%)
11
ALGENGenoway S A Inh Eo 15
3.05 €
(-19.95%)
104.04k
ALGBEGlobal Bioenergies
0.96 €
(-17.24%)
81.55k
ATOAtos SE
0.0022 €
(10.00%)
2.97B
BCPBanco Comercial Portugues SA
0.511 €
(0.75%)
46.23M
ALVERVergnet
0.0015 €
(0.00%)
18.86M
ALCYBCybergun
0.0001 €
(0.00%)
13.76M
ALADOAdomos
0.0002 €
(0.00%)
10.2M
al44 al44 3 minutos hace
Will Trump be a Titan Worthy of McKinley?

By J. Robert Smith


Trump’s America First principles favor U.S. business, with an emphasis on entrepreneurs, small businesses, and independent contractors (a growing cohort). Tariffs, as mentioned, are a means of leveling
Patswil Patswil 3 minutos hace
Taking out stops , or what?
FNMA
Lonewolf1 Lonewolf1 3 minutos hace
About 40 million of ask slapping in the first 2 minutes of trading. Eased off after that.

Tick tock.....
CGAC
Tree Tree 3 minutos hace
MYTH!!!
Negative 4 here right now. LOL
Same thing going on here that is going on in Philly. LOL

Man, I am struggling to get a read on your game. LOL
I think I like you guys and laying the points
The best bet is probably one of your patented teasers. Tease d
Countmein Countmein 3 minutos hace
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

https://ih.advfn.com/stock-market/NYSE/home-bancshares-HOMB/stock-news/95283447/form-4-a-statement-of-changes-in-beneficial-owne

Count
HOMB
KngmAz KngmAz 4 minutos hace
Wow - GOING UP - DON'T MISS OUT!!
HGRAF
snow snow 4 minutos hace
imindog It is possible to have net revenue and at the same time lose more money than the net revenue. Are you clueless?
IQST
timberwolf7 timberwolf7 4 minutos hace
Who sells at this low price?

-those who bought in hoping to catch
something going 'on'?

-those hoping to catch a quick 'buck'

been teaching folks for some years now, the market is a game of
'research' involving harsh, critical analysis and
TNXP
AugustaFriends AugustaFriends 4 minutos hace
$ASNS bought at 1.41 AVG 14,000 shares -- with news today

https://finance.yahoo.com/news/actelis-networks-secures-significant-order-134100887.html
ASNS
freecs freecs 4 minutos hace
Shh Miro-bot.
HIRU
diggitydoodle diggitydoodle 4 minutos hace
FOXO down.
RNVA nothing.
All the baseless hype continues to go from...
"it's go time", to "wait wait, wait".
RNVA!!$$??????????????
FOXO RNVA
MrRubs92 MrRubs92 4 minutos hace
Navy is the got damn man. Stfu
FNMA
$PennyMover $PennyMover 4 minutos hace
It is not the company selling, but a note holder is
GRLF
Paulie Cashews Paulie Cashews 4 minutos hace
Don't compare activity with achievement.

The Lion doesn't worry about what the chihuahuas are talking about.

Pay up, deadbeat!

adserv.stocksite.com/images/paulie/ihstupid1.jpg

www.investorshub.com/boards/board.asp?board_id=2581 Paulie's P
Chartmaster Chartmaster 4 minutos hace
Yup! Above 20 is all BLUE SKIES!!!
SMCE
trader53 trader53 5 minutos hace
DPLS 0.0008 - Point of Maximum Financial Opportunity

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175351550

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
DPLS
Sodapop42 Sodapop42 5 minutos hace
LMAO I'm not worried about it Gobles, I did alright during the pink current pump, too bad you can't say the same Grundle🤡🤡🤡🤡
PHIL
firebag1 firebag1 5 minutos hace
thats hilarious CJ lol
HMBL
CelestialOgre14 CelestialOgre14 5 minutos hace
0.52 EOD
ELTP
chuck4345 chuck4345 6 minutos hace
My guess is it’s done till it’s get a bid again
GTCH
abazaba375 abazaba375 6 minutos hace
This one has all the ingredients.003s soon 
SMCE
Trooperstocks Trooperstocks 6 minutos hace
Hopefully you get filled soon. $IVDN
IVDN
jimr1717 jimr1717 6 minutos hace
It’s two cent Tuesday! No one is fooled
IFUS
Fallingknife75 Fallingknife75 6 minutos hace
Nice, now that they have the mill running efficiently they have negotiated to keep a higher percent of the upcoming profits from it.

Jared rocks,

Knife
NBRI
sharkey1 sharkey1 6 minutos hace
Yes Rocky, I agree, The logic behind when it's 49999 and 50, If you an investor
and you want to buy lets say 10,000 shares for the day, you can put your order in for 49999
and wait or 50 and it goes through in a millisecond, sure you might be out a few penny's
but you made
ELTP

Su Consulta Reciente

Delayed Upgrade Clock